Clinical Trial Update: Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 HERMES pilot study evaluating inflammatory mRNA expression in macrophages and endothelial function with short-acting human insulin analogs in Type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Short-acting human insulin analogs (insulin (short-acting analogs))

Snippet

Sponsor: ikfe-CRO GmbH | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN